
Managing Treatment-Related Toxicities in Relapsed/Refractory Multiple Myeloma
In this segment, Elizabeth Bohannon shares practical strategies she used to manage treatment-related toxicities during her relapsed/refractory multiple myeloma journey, particularly dry mouth, oral health changes, nail changes, and skin toxicity associated with talquetamab.
Episodes in this series

In this segment, Elizabeth Bohannon shares practical strategies she used to manage treatment-related toxicities during her relapsed/refractory multiple myeloma journey, particularly dry mouth, oral health changes, nail changes, and skin toxicity associated with talquetamab. She describes researching supportive approaches and working with members of her care team, including her dentist, to address oral health and protect against dental complications during treatment. Elizabeth also discusses measures she used to manage nail changes and protect sensitive, cracked skin on her hands. Samantha Shenoy, NP, provides additional context on some of the supportive approaches Elizabeth describes, including pilocarpine-containing compounded preparations for dry mouth and protective finger coverings. The conversation emphasizes the value of proactive symptom management, collaboration with supportive care professionals, and individualized strategies to help patients manage adverse effects and maintain daily functioning during treatment for relapsed/refractory multiple myeloma.



























































